Key facts
- This page summarizes Michael D. Webb's Form 3 filing for Enveric Biosciences, Inc. (ENVB).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 22 Jun 2022, 16:15.
Michael D. Webb - 13 Jun 2022 Form 3 Insider Report for Enveric Biosciences, Inc. (ENVB)
- Reporting relationship
- Director
- Issuer ticker
- ENVB
- Reported as of
- 13 Jun 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 22 Jun 2022, 16:15:41 UTC
- Next SEC filing
- 11 Oct 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael D. Webb
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael D. Webb filed Form 3 for Enveric Biosciences, Inc. (ENVB) on 22 Jun 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.